Breast Biopsy Market size is estimated to be $1.15 billion in 2019, growing at a CAGR of 5.5% during the forecast period 2020-2025.Increasing prevalence of breast cancer among women after menopause, rising population of women and developments in technology is a major factor driving the breast biopsy market during the forecast period 2020-2025.Moreover, the use of stereotactic biopsy in hospitals performed within an hour is further contributing to its market growth. A breast biopsy is a medical procedure in which a sample of breast tissue is removed and sent to the laboratory for testing. In addition a breast biopsy is the best way to evaluate if a suspicious lump or portion of the breast is cancerous. Moreover, according to Effective Health Care Program about one in eight women in the U.S. would develop invasive breast cancer during their lifetime. Approximately 290,000 new cases of breast cancer are diagnosed each year in the U.S. and more than 230,000 of the cases are invasive breast cancer. Furthermore Fine-needle aspiration biopsy is the first pathological diagnosis method used for diagnosis and screening of breast diseases owing to its rapid, safe and less painful procedure.
- Hospitals accounted for the largest market share in 2019 owing to the increasing number of breast cancer patients around the world.
- Increase in Breast Cancer Screening Programs is a major factor fueling the demand of Breast Biopsy Market during the forecast period 2020-2025.
- By guided technology, the Ultrasound guided biopsy is poised to be the fastest growing with a CAGR of 4.8% during the forecast period 2020-2025. This is owing to the demand for minimally invasive surgical procedures.
- Detailed analysis of the Strength, Weakness, and opportunities of the prominent players operating in the market will be provided in the oxygenator market report.
By Type- Segment Analysis
By Type the Needle Breast Biopsy held the largest market share in 2019 owing to the more accurate assessment of breast mass than fine needle aspiration since the larger core needle usually removes enough tissue for the pathologist to evaluate abnormal cells in relation to the surrounding small sample of breast tissue taken in the specimen. Moreover, technological developments has led to vacuum assisted biopsy which is able to remove approximately twice the amount of breast tissue compared with core needle biopsy while still offering the patient a minimal invasive breast biopsy procedure. In addition vacuum assisted core biopsy is an alternative to surgical biopsy. It allows the area of abnormality to be precisely located using image guidance so that only samples from region of interest are removed. In addition it is performed with outpatient procedure under local anesthetic.
By End-Use- Segment Analysis
Hospitals accounted for the largest market share in 2019 owing to the increasing number of breast cancer patients around the world. Furthermore, trained doctors in the hospitals usually perform biopsy thereby hospital are a major place for biopsy. Moreover, in breast biopsy the doctor remove a small amount of tissue usually by a needle or surgery. In addition most of the surgical biopsies are done in hospital or surgical centers thereby driving the demand of breast biopsy during the forecast period 2020-2025.
Geography- Segment Analysis
North America dominated the Breast Biopsy Market with a region share 36% in 2019 followed by Europe and APAC. Increasing adoption of advanced medical technology and rising development by companies operating on cancer diagnostics is a major factor driving the breast biopsy market during the forecast period 2020-2025.Futhermore, growing awareness among people regarding early diagnosis and government initiatives are further contributing to its market growth. Moreover, according to U.S. Department of Health and Human Services more than 1 million people have breast biopsies each year in the U.S. About 20% of these biopsies yield a diagnosis of breast cancer.
Drivers –Breast Biopsy Market
- Rising Number of Breast Cancer Patients
Rising Number of Breast Cancer Patients around the world is a major factor driving the Breast Biopsy Market during the forecast period 2020-2025.Increasing women population along with an increase in the breast cancer patients is driving its market growth. Moreover, according to the U.S Breast Cancer Statistics in 2020 an estimated 276,480 new cases of invasive breast cancer are to be diagnosed in women in the U.S., along with 48,530 new cases of non-invasive breast cancer.
- Increasing In Breast Cancer Screening Programs
Increase in Breast Cancer Screening Programs is a major factor fueling the demand of Breast Biopsy Market during the forecast period 2020-2025.Screening Mammography is the most common and widely practiced breast cancer screening modularity across the world. It offers several advantages such as reducing the risk of dying from breast cancer, reducing the risk of having to undergo chemotherapy and allows women to know the healthier of breast.
Challenges – Breast Biopsy Market
- Infection Risk Associated with Breast Biopsy Procedure
Infection risk associated with breast biopsy procedure serves as a major setback for the growth of breast biopsy market during the forecast period 2020-2025.Futhermore, during or after biopsy procedure the patient may experience mild pain, bruising and bleeding at the biopsy site thereby restraining its market growth. Other risk of image- guided biopsy may include neck pain during a stereotactic procedure and arm pain during an ultrasound procedure.
Breast Biopsy Market Industry Outlook
Product Launches, Merger & Acquistion, joint ventures and R&D activities are key strategies adopted by the players in the Breast Biopsy Market. Breast Biopsy Market top 10 companies are Becton, Dickinson, C.R. Bard Inc, Devicor Medical Products Inc, Hologic Inc, Cardinal Health Inc, Angiotech, Galini SRL, Johnson & Johnson and GE Healthcare.
- August 2019: Imago Systems Image Visualization Company collaborated with Mayo Clinic for Breast Imaging.